Yamagishi R, Niwa M, Kondo S, Sakuragawa N, Koide T
Thromb Res. 1984 Dec 15;36(6):633-42. doi: 10.1016/0049-3848(84)90202-0.
Heparin cofactor II (HC II) has been purified from human plasma by a modification of the method described by Tollefsen et al. (J. Biol. Chem., 257, 2162, 1982) and abilities of dextran sulfate and various glycosaminoglycans to activate the antithrombin activities of HC II and antithrombin III (AT III) were studied. By the purification method described here, highly purified HC II with the same specific activity as reported by Tollefsen et al. was obtained with a higher yield and in a shorter purification time. Heparin, dextran sulfate and chondroitin polysulfates 1 and 5 activated both HC II and AT III, while dermatan sulfate activated only HC II. Dextran sulfate was almost as active as heparin in the activation of HC II and AT III, indicating that in the interactions of heparin with HC II and AT III, sulfate groups of heparin are more important than carboxyl groups. When mixed with thrombin in the presence of dermatan sulfate, normal human plasma showed antithrombin activity which was not due to AT III but to HC II only. HC II did not inhibit factor Xa or plasmin in the presence of any glycosaminoglycans or dextran sulfate, suggesting that HC II would be a specific inhibitor of thrombin.
通过对托勒夫森等人(《生物化学杂志》,257卷,2162页,1982年)所述方法进行改进,从人血浆中纯化出了肝素辅因子II(HC II),并研究了硫酸葡聚糖和各种糖胺聚糖激活HC II和抗凝血酶III(AT III)抗凝血酶活性的能力。采用此处所述的纯化方法,获得了比活性与托勒夫森等人报道相同的高纯度HC II,且产率更高,纯化时间更短。肝素、硫酸葡聚糖以及硫酸软骨素1和5均可激活HC II和AT III,而硫酸皮肤素仅激活HC II。在激活HC II和AT III方面,硫酸葡聚糖的活性几乎与肝素相同,这表明在肝素与HC II和AT III的相互作用中,肝素的硫酸基团比羧基更为重要。在硫酸皮肤素存在的情况下,正常人血浆与凝血酶混合时表现出的抗凝血酶活性并非源于AT III,而仅源于HC II。在任何糖胺聚糖或硫酸葡聚糖存在的情况下,HC II均不抑制因子Xa或纤溶酶,这表明HC II可能是凝血酶的特异性抑制剂。